Nebivolol is devoid of intrinsic sympathomimetic activity

Nebivolol is a chemically novel, potent and selective β 1-adrenoceptor-blocking agent that acutely lowers arterial blood pressure in hypertensive patients and rats without depressing, or even enhancing, left ventricular function. These properties could be compatible with a partial agonistic effect o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pharmacology 1989-01, Vol.159 (1), p.89-95
Hauptverfasser: Janssens, W.J., Van de Water, A., Xhonneux, R., Reneman, R.S., Van Nueten, J.M., Janssen, P.A.J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 95
container_issue 1
container_start_page 89
container_title European journal of pharmacology
container_volume 159
creator Janssens, W.J.
Van de Water, A.
Xhonneux, R.
Reneman, R.S.
Van Nueten, J.M.
Janssen, P.A.J.
description Nebivolol is a chemically novel, potent and selective β 1-adrenoceptor-blocking agent that acutely lowers arterial blood pressure in hypertensive patients and rats without depressing, or even enhancing, left ventricular function. These properties could be compatible with a partial agonistic effect of β-adrenoceptor-blocking agents. It was the aim of the present study to investigate whether nebivolol has intrinsic sympathomimetic properties. The study was performed on reserpinized dogs and spontaneously hypertensive rats, and on various isolated tissues from various species. Unlike pindolol and practolol, nebivolol did not exert a stimulating effect on the heart rate and left ventricular function in reserpinized animals and/or in isolated atria of reserpinized rats at doses that are clinically active. Nebivolol did not induce relaxation of isolated coronary arteries and saphenous veins at concentrations that block β-adrenoceptors. These findings indicate that nebivolol is devoid of intrinsic sympathomimetic activity at clinically relevant doeses.
doi_str_mv 10.1016/0014-2999(89)90047-2
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78914288</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014299989900472</els_id><sourcerecordid>78914288</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-e5ca239f84b6e4ab5219f90286b6cd0e613483a591a147f2cddbd6c733fb17413</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMoun78A4UeRPRQzaRJm1wEWfwC0YueQ5pMMdI2a9Jd2H9v1132qKchzDPvTB5CToFeA4XyhlLgOVNKXUp1pSjlVc52yARkpXJaAdslky1yQA5T-qKUCsXEPtlnohSsUBOiXrH2i9CGNvMpc7gI3mWhyXw_RN8nb7O07GZm-Ayd73AY38YOfuGH5THZa0yb8GRTj8jHw_379Cl_eXt8nt695JZDNeQorBk3NZLXJXJTCwaqUZTJsi6to1hCwWVhhAIDvGqYda52pa2Koqmh4lAckYt17iyG7zmmQXc-WWxb02OYJ11JBZxJ-S8IAgpVwCqRr0EbQ0oRGz2LvjNxqYHqlVq98qZX3rRU-letZuPY2SZ_XnfotkMbl2P_fNM3yZq2iaa3Pm2x8UelAjFit2sMR2kLj1En67G36HxEO2gX_N93_AC9lZQs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15139311</pqid></control><display><type>article</type><title>Nebivolol is devoid of intrinsic sympathomimetic activity</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Janssens, W.J. ; Van de Water, A. ; Xhonneux, R. ; Reneman, R.S. ; Van Nueten, J.M. ; Janssen, P.A.J.</creator><creatorcontrib>Janssens, W.J. ; Van de Water, A. ; Xhonneux, R. ; Reneman, R.S. ; Van Nueten, J.M. ; Janssen, P.A.J.</creatorcontrib><description>Nebivolol is a chemically novel, potent and selective β 1-adrenoceptor-blocking agent that acutely lowers arterial blood pressure in hypertensive patients and rats without depressing, or even enhancing, left ventricular function. These properties could be compatible with a partial agonistic effect of β-adrenoceptor-blocking agents. It was the aim of the present study to investigate whether nebivolol has intrinsic sympathomimetic properties. The study was performed on reserpinized dogs and spontaneously hypertensive rats, and on various isolated tissues from various species. Unlike pindolol and practolol, nebivolol did not exert a stimulating effect on the heart rate and left ventricular function in reserpinized animals and/or in isolated atria of reserpinized rats at doses that are clinically active. Nebivolol did not induce relaxation of isolated coronary arteries and saphenous veins at concentrations that block β-adrenoceptors. These findings indicate that nebivolol is devoid of intrinsic sympathomimetic activity at clinically relevant doeses.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/0014-2999(89)90047-2</identifier><identifier>PMID: 2565239</identifier><identifier>CODEN: EJPHAZ</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Adrenergic beta-Antagonists - pharmacology ; Animals ; Antihypertensive agents ; Atria (isolated) ; Benzopyrans - pharmacology ; Biological and medical sciences ; Blood Pressure - drug effects ; Blood vessels (isolated) ; Cardiovascular system ; Dogs ; Electrocardiography ; Ethanolamines - pharmacology ; Female ; gb1-Adrenoceptor blockade ; Guinea Pigs ; Heart Rate - drug effects ; Hemodynamics - drug effects ; In Vitro Techniques ; Intrinsic sympathomimetic activity ; Isometric Contraction - drug effects ; Male ; Medical sciences ; Muscle, Smooth, Vascular - drug effects ; Nebivolol ; Pharmacology. Drug treatments ; Pindolol ; Practolol ; Rats ; Rats, Inbred SHR ; Rats, Inbred Strains ; Reserpine - pharmacology ; Reserpinized animals ; Sympathomimetics</subject><ispartof>European journal of pharmacology, 1989-01, Vol.159 (1), p.89-95</ispartof><rights>1989</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-e5ca239f84b6e4ab5219f90286b6cd0e613483a591a147f2cddbd6c733fb17413</citedby><cites>FETCH-LOGICAL-c417t-e5ca239f84b6e4ab5219f90286b6cd0e613483a591a147f2cddbd6c733fb17413</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0014299989900472$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7336915$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2565239$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Janssens, W.J.</creatorcontrib><creatorcontrib>Van de Water, A.</creatorcontrib><creatorcontrib>Xhonneux, R.</creatorcontrib><creatorcontrib>Reneman, R.S.</creatorcontrib><creatorcontrib>Van Nueten, J.M.</creatorcontrib><creatorcontrib>Janssen, P.A.J.</creatorcontrib><title>Nebivolol is devoid of intrinsic sympathomimetic activity</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Nebivolol is a chemically novel, potent and selective β 1-adrenoceptor-blocking agent that acutely lowers arterial blood pressure in hypertensive patients and rats without depressing, or even enhancing, left ventricular function. These properties could be compatible with a partial agonistic effect of β-adrenoceptor-blocking agents. It was the aim of the present study to investigate whether nebivolol has intrinsic sympathomimetic properties. The study was performed on reserpinized dogs and spontaneously hypertensive rats, and on various isolated tissues from various species. Unlike pindolol and practolol, nebivolol did not exert a stimulating effect on the heart rate and left ventricular function in reserpinized animals and/or in isolated atria of reserpinized rats at doses that are clinically active. Nebivolol did not induce relaxation of isolated coronary arteries and saphenous veins at concentrations that block β-adrenoceptors. These findings indicate that nebivolol is devoid of intrinsic sympathomimetic activity at clinically relevant doeses.</description><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Antihypertensive agents</subject><subject>Atria (isolated)</subject><subject>Benzopyrans - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Blood vessels (isolated)</subject><subject>Cardiovascular system</subject><subject>Dogs</subject><subject>Electrocardiography</subject><subject>Ethanolamines - pharmacology</subject><subject>Female</subject><subject>gb1-Adrenoceptor blockade</subject><subject>Guinea Pigs</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>In Vitro Techniques</subject><subject>Intrinsic sympathomimetic activity</subject><subject>Isometric Contraction - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle, Smooth, Vascular - drug effects</subject><subject>Nebivolol</subject><subject>Pharmacology. Drug treatments</subject><subject>Pindolol</subject><subject>Practolol</subject><subject>Rats</subject><subject>Rats, Inbred SHR</subject><subject>Rats, Inbred Strains</subject><subject>Reserpine - pharmacology</subject><subject>Reserpinized animals</subject><subject>Sympathomimetics</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LxDAQhoMoun78A4UeRPRQzaRJm1wEWfwC0YueQ5pMMdI2a9Jd2H9v1132qKchzDPvTB5CToFeA4XyhlLgOVNKXUp1pSjlVc52yARkpXJaAdslky1yQA5T-qKUCsXEPtlnohSsUBOiXrH2i9CGNvMpc7gI3mWhyXw_RN8nb7O07GZm-Ayd73AY38YOfuGH5THZa0yb8GRTj8jHw_379Cl_eXt8nt695JZDNeQorBk3NZLXJXJTCwaqUZTJsi6to1hCwWVhhAIDvGqYda52pa2Koqmh4lAckYt17iyG7zmmQXc-WWxb02OYJ11JBZxJ-S8IAgpVwCqRr0EbQ0oRGz2LvjNxqYHqlVq98qZX3rRU-letZuPY2SZ_XnfotkMbl2P_fNM3yZq2iaa3Pm2x8UelAjFit2sMR2kLj1En67G36HxEO2gX_N93_AC9lZQs</recordid><startdate>19890102</startdate><enddate>19890102</enddate><creator>Janssens, W.J.</creator><creator>Van de Water, A.</creator><creator>Xhonneux, R.</creator><creator>Reneman, R.S.</creator><creator>Van Nueten, J.M.</creator><creator>Janssen, P.A.J.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19890102</creationdate><title>Nebivolol is devoid of intrinsic sympathomimetic activity</title><author>Janssens, W.J. ; Van de Water, A. ; Xhonneux, R. ; Reneman, R.S. ; Van Nueten, J.M. ; Janssen, P.A.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-e5ca239f84b6e4ab5219f90286b6cd0e613483a591a147f2cddbd6c733fb17413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Antihypertensive agents</topic><topic>Atria (isolated)</topic><topic>Benzopyrans - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Blood vessels (isolated)</topic><topic>Cardiovascular system</topic><topic>Dogs</topic><topic>Electrocardiography</topic><topic>Ethanolamines - pharmacology</topic><topic>Female</topic><topic>gb1-Adrenoceptor blockade</topic><topic>Guinea Pigs</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>In Vitro Techniques</topic><topic>Intrinsic sympathomimetic activity</topic><topic>Isometric Contraction - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle, Smooth, Vascular - drug effects</topic><topic>Nebivolol</topic><topic>Pharmacology. Drug treatments</topic><topic>Pindolol</topic><topic>Practolol</topic><topic>Rats</topic><topic>Rats, Inbred SHR</topic><topic>Rats, Inbred Strains</topic><topic>Reserpine - pharmacology</topic><topic>Reserpinized animals</topic><topic>Sympathomimetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Janssens, W.J.</creatorcontrib><creatorcontrib>Van de Water, A.</creatorcontrib><creatorcontrib>Xhonneux, R.</creatorcontrib><creatorcontrib>Reneman, R.S.</creatorcontrib><creatorcontrib>Van Nueten, J.M.</creatorcontrib><creatorcontrib>Janssen, P.A.J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Janssens, W.J.</au><au>Van de Water, A.</au><au>Xhonneux, R.</au><au>Reneman, R.S.</au><au>Van Nueten, J.M.</au><au>Janssen, P.A.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nebivolol is devoid of intrinsic sympathomimetic activity</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>1989-01-02</date><risdate>1989</risdate><volume>159</volume><issue>1</issue><spage>89</spage><epage>95</epage><pages>89-95</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><coden>EJPHAZ</coden><abstract>Nebivolol is a chemically novel, potent and selective β 1-adrenoceptor-blocking agent that acutely lowers arterial blood pressure in hypertensive patients and rats without depressing, or even enhancing, left ventricular function. These properties could be compatible with a partial agonistic effect of β-adrenoceptor-blocking agents. It was the aim of the present study to investigate whether nebivolol has intrinsic sympathomimetic properties. The study was performed on reserpinized dogs and spontaneously hypertensive rats, and on various isolated tissues from various species. Unlike pindolol and practolol, nebivolol did not exert a stimulating effect on the heart rate and left ventricular function in reserpinized animals and/or in isolated atria of reserpinized rats at doses that are clinically active. Nebivolol did not induce relaxation of isolated coronary arteries and saphenous veins at concentrations that block β-adrenoceptors. These findings indicate that nebivolol is devoid of intrinsic sympathomimetic activity at clinically relevant doeses.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>2565239</pmid><doi>10.1016/0014-2999(89)90047-2</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 1989-01, Vol.159 (1), p.89-95
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_78914288
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adrenergic beta-Antagonists - pharmacology
Animals
Antihypertensive agents
Atria (isolated)
Benzopyrans - pharmacology
Biological and medical sciences
Blood Pressure - drug effects
Blood vessels (isolated)
Cardiovascular system
Dogs
Electrocardiography
Ethanolamines - pharmacology
Female
gb1-Adrenoceptor blockade
Guinea Pigs
Heart Rate - drug effects
Hemodynamics - drug effects
In Vitro Techniques
Intrinsic sympathomimetic activity
Isometric Contraction - drug effects
Male
Medical sciences
Muscle, Smooth, Vascular - drug effects
Nebivolol
Pharmacology. Drug treatments
Pindolol
Practolol
Rats
Rats, Inbred SHR
Rats, Inbred Strains
Reserpine - pharmacology
Reserpinized animals
Sympathomimetics
title Nebivolol is devoid of intrinsic sympathomimetic activity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-20T21%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nebivolol%20is%20devoid%20of%20intrinsic%20sympathomimetic%20activity&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Janssens,%20W.J.&rft.date=1989-01-02&rft.volume=159&rft.issue=1&rft.spage=89&rft.epage=95&rft.pages=89-95&rft.issn=0014-2999&rft.eissn=1879-0712&rft.coden=EJPHAZ&rft_id=info:doi/10.1016/0014-2999(89)90047-2&rft_dat=%3Cproquest_cross%3E78914288%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15139311&rft_id=info:pmid/2565239&rft_els_id=0014299989900472&rfr_iscdi=true